Cue Biopharma Board Transition with New Appointments
Cue Biopharma announced the transition of its board as the company advances its strategic growth and development efforts. Effective May 29, four independent directors have resigned from the board. Simultaneously, the company appointed Daniel Camardo and Viola Meehan as new directors. Camardo currently serves as President of Immedica Pharma North America, and Meehan is an independent director for the Federal Savings Bank with over 30 years of finance and board experience.
